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STUDY QUESTION: Is cord blood DNA methylation associated with having been conceived by medically assisted reproduction?
SUMMARY ANSWER: This study does not provide strong evidence of an association of conception by medically assisted reproduction
with variation in infant blood cell DNA methylation.
WHAT IS KNOWN ALREADY: Medically assisted reproduction consists of procedures used to help infertile/subfertile couples
conceive, including ART. Due to its importance in gene regulation during early development programming, DNA methylation and its per-
turbations associated with medically assisted reproduction could reveal new insights into the biological effects of assisted reproductive
technologies and potential adverse offspring outcomes.
STUDY DESIGN, SIZE, DURATION: We investigated the association of DNA methylation and medically assisted reproduction using a
case–control study design (N¼ 205 medically assisted reproduction cases and N¼ 2439 naturally conceived controls in discovery cohorts;
N¼ 149 ART cases and N¼ 58 non-ART controls in replication cohort).
PARTICIPANTS/MATERIALS, SETTINGS, METHODS: We assessed the association between medically assisted reproduction and
DNA methylation at birth in cord blood (205 medically assisted conceptions and 2439 naturally conceived controls) at >450 000 CpG
sites across the genome in two sub-samples of the UK Avon Longitudinal Study of Parents and Children (ALSPAC) and two sub-samples
of the Norwegian Mother, Father and Child Cohort Study (MoBa) by meta-analysis. We explored replication of findings in the Australian
Clinical review of the Health of adults conceived following Assisted Reproductive Technologies (CHART) study (N¼ 149 ART conceptions
and N¼ 58 controls).
MAIN RESULTS AND THE ROLE OF CHANCE: The ALSPAC and MoBa meta-analysis revealed evidence of association between
conception by medically assisted reproduction and DNA methylation (false-discovery-rate-corrected P-value < 0.05) at five CpG sites
which are annotated to two genes (percentage difference in methylation per CpG, cg24051276: Beta¼ 0.23 (95% CI 0.15,0.31);
cg00012522: Beta¼ 0.47 (95% CI 0.31, 0.63); cg17855264: Beta¼ 0.31 (95% CI 0.20, 0.43); cg17132421: Beta¼ 0.30 (95% CI 0.18,
0.42); cg18529845: Beta¼ 0.41 (95% CI 0.25, 0.57)). Methylation at three of these sites has been previously linked to cancer, aging, HIV
infection and neurological diseases. None of these associations replicated in the CHART cohort. There was evidence of a functional role
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of medically assisted reproduction-induced hypermethylation at CpG sites located within regulatory regions as shown by putative transcrip-
tion factor binding and chromatin remodelling.
LIMITATIONS, REASONS FOR CAUTIONS: While insufficient power is likely, heterogeneity in types of medically assisted reproduc-
tion procedures and between populations may also contribute. Larger studies might identify replicable variation in DNA methylation at
birth due to medically assisted reproduction.
WIDER IMPLICATIONS OF THE FINDINGS: Newborns conceived with medically assisted procedures present with divergent DNA
methylation in cord blood white cells. If these associations are true and causal, they might have long-term consequences for offspring health.
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Introduction
The number of children conceived using ART has increased steadily
over the last four decades. ART include any treatment that consists of
in vitro handling of human sperm, oocytes and embryos such as IVF/
ICSI and gamete and embryo cryopreservation. More broadly, medi-
cally assisted reproduction refers to any treatment/intervention for
fertility impairment and infertility, including ART and other procedures
such as ovulation induction (OI) and intrauterine insemination that
might use hormones to stimulate oocyte production but do not usually
handle gametes (Zegers-Hochschild et al., 2017). The timing of devel-
opmental epigenetic reprogramming coinciding with fertility interven-
tions and the susceptibility of DNA methylation to environmental
stresses have led to suggestions that fertility interventions may alter
the offspring’s DNA methylation patterns (Canovas et al., 2017).
Alterations in the embryo demethylation and re-methylation processes
due to medically assisted reproduction can be caused by nutritional
stress due to in vitro culture conditions, hormonal overstimulation of
the ovary beyond the physiological range due to superovulation-induc-
ing procedures, or a combination of the two exposures (Doherty
et al., 2000; Mann et al., 2004; Market-Velker et al., 2010a, 2010b;
Market-Velker et al., 2012; White et al., 2015; Velker et al., 2017).
Medically assisted reproduction procedures may subject gametes and
early embryos to environmental stress which may impact the develop-
ment of the foetus, for example, by disruptions in the expression of
imprinted genes (Sakian et al., 2015). Gamete and embryo
cryopreservation methods can also affect DNA methylation (Van
Heertum and Weinerman, 2018; Cao et al., 2019).
Earlier studies investigating the association of ART and DNA meth-
ylation at birth have focused on imprinted genes and found mixed
results which overall point to weak evidence of any association when
meta-analyzed (Lazaraviciute et al., 2014). Other studies have included
other non-imprinted candidate genes, resulting in the discovery of
some associations between treatment and methylation in cord blood
and placental cells (Katari et al., 2009; Tierling et al., 2010; Song et al.,
2015). More recent studies have moved from a candidate gene to a
genome-wide analysis approach. Some genome wide studies have
identified differential methylation in neonatal blood cells between ART
(or, more specifically, IVF) and controls (Melamed et al., 2015; Estill
et al., 2016; Castillo-Fernandez et al., 2017; El Hajj et al., 2017;
Novakovic et al., 2019). However, other similar studies have found lit-
tle evidence (Gentilini et al., 2018; Choufani et al., 2019), perhaps ow-
ing to small sample sizes, comparisons with different procedures
across some studies and consequently insufficient power to detect
true associations. Only one study has included more than 100 concep-
tions through ART (Novakovic et al., 2019), and, although it found
several associations, it did not control for potential confounding from
parental characteristics.
Whilst different ART procedures have been associated with a wide
range of adverse perinatal and longer-term offspring outcomes (Kallen
et al., 2010; Hansen et al., 2013; Chen and Heilbronn, 2017; Elias
et al., 2020), a large recent study with follow-up to 22–35 years, did































































































not confirm the associations with longer-term outcomes (Halliday
et al., 2019). Moreover, the extent to which any associations with ad-
verse outcomes are related to multiple pregnancies, the effect of un-
derlying causes of infertility, selection bias or confounding is unclear. In
relation to adverse perinatal outcomes such as pregnancy loss, pre-
term birth and small for gestational age, increasing evidence suggests
that multiple pregnancies explain much of the increased risk (Nelson
and Lawlor, 2011; Lawlor and Nelson, 2012). Recent evidence from
the European Surveillance of Congenital Anomalies (EUROCAT) sug-
gests that a substantial proportion of associations with congenital
anomalies may be due to underlying causes of infertility rather than
ART per se (Davies et al., 2012; Levi Setti et al., 2016). However,
these and studies of ART with longer-term offspring outcomes often
rely on large-scale clinical and administrative datasets with minimal
data on potential confounders. The use of longitudinal birth cohorts
may be useful for assessing causal effects of ART or, more broadly,
medically assisted reproduction on offspring health as they typically
collect data on a range of potential confounders. The identification of
associations of medically assisted reproduction with differential DNA
methylation in genes that have established associations with health out-
comes could be used to prioritize offspring disease outcomes for
more detailed causal analyses that might be mediated by DNA methyl-
ation. Interrogating DNA methylation and its potential role as a medi-
ating mechanism linking ART or, more broadly, medically assisted
reproduction to health consequences in the offspring may provide
insights into the biological pathways involved.
The aim of this study was to determine the association between
having been conceived through medically assisted reproduction and ge-
nome-wide variation in cord blood DNA methylation at >450 000
CpG sites using the Illumina Methylation 450K BeadChip across multi-
ple cohorts. Medically assisted reproduction is used here to describe
the exposure studied as one of the cohorts included did not provide
sufficient information for us to be certain the procedures were ART.
Building on previous studies, we have used a multi-cohort approach
with meta-analysis and replication, while interrogating the whole ge-
nome. We have also used functional analysis methods to attempt to
characterize the biological implications of the findings in the context of
long-term health outcomes.
Materials and methods
The overall approach to our methods was to pool results from epige-
nome-wide association studies (EWAS) in two general population birth
cohorts, the Avon Longitudinal Study of Parents and Children
(ALSPAC) and the Norwegian Mother, Father, and Child Birth Cohort
(MoBa), as discovery analyses. We then explored replication of any
discovery associations in an independent study, the ‘Clinical review of
the Health of adults conceived following Assisted Reproductive
Technologies’ (CHART) cohort.
Study populations
Avon longitudinal study of parents and children (ALSPAC)
ALSPAC is a population birth cohort that enrolled 14 541 pregnancies
from residents in and around the city of Bristol in the South West of
the UK with expected delivery dates between 1991 and 1992 (Boyd
et al., 2013; Fraser et al., 2013). The study website contains details of
all the data that is available through a fully searchable data dictionary
and variable search tool: http://www.bristol.ac.uk/alspac/research
ers/our-data/.
In ALSPAC, a subset of 1018 mother–offspring pairs had DNA
methylation measured within the Accessible Resource for Integrated
Epigenomics Studies (ARIES) (http://www.ariesepigenomics.org.uk/)
(Relton et al., 2015). ALSPAC–ARIES participants were selected based
on the availability of DNA samples at two time points for mothers
and three time points for the offspring (Relton et al., 2015). After qual-
ity control checks and exclusion of multiple pregnancies, N¼ 857 pairs
had reliable cord blood DNA methylation data to include in this study.
After removing N¼ 21 participants without data about method of
conception and a further N¼ 52 participants without all the covari-
ates, we had a sample of N¼ 784 (77% of the original ARIES sam-
ples). In comparison to the overall ALSPAC cohort, the subset of
ARIES mother–offspring pairs is slightly older, more likely to have a
non-manual occupation and less likely to have smoked during preg-
nancy (Relton et al., 2015).
A second ALSPAC subset, the ALSPAC-Medically assisted repro-
duction (ALSPAC-MAR) subsample, also had cord blood DNA meth-
ylation measured. This subset consisted of additional ALSPAC
participants selected to maximize the number of children conceived
through medically assisted reproduction and hence increase power.
One hundred seventy-eight infants conceived with medically assisted
reproduction procedures, with cord blood samples, and 241 naturally
conceived controls were selected for epigenome wide DNA methyla-
tion analyses. The 241 naturally conceived participants were not a ran-
dom sample but consisted of participants selected for other epigenetic
experiments that were run in the lab at the same time as the medically
assisted reproduction cases (arthritis, diabetes, eating disorder, pre-
eclampsia, hypertension, BMI, child autism and child undescended tes-
ticle). The distribution of these traits across the ALSPAC-MAR cases
and control participants is shown in Supplementary Table SI. After re-
moving those without all the covariates, there were N¼ 345
participants (82% of the additional subset; N¼ 155 cases and N¼ 190
non-controls). In both subsets of ALSPAC, information on the specific
procedure used meant that we could not distinguish ART from the
broader definition of medically assisted reproduction and hence for
this cohort and in general in relation to exposure we use the latter
term rather than ART. Written informed consent was obtained from
all participants. The protocols and types of chip used for measurement
of epigenome wide DNA methylation were the same for both
ALSPAC samples (Relton et al., 2015). Ethical approval for the
ALSPAC data was granted by the ALSPAC law and ethics committee
and local Research Ethics Committees. The details of the ethical ap-
proval at each stage of the study can be found in the ALSPAC website:
http://www.bristol.ac.uk/alspac/researchers/research-ethics/.
The Norwegian Mother and Child Cohort Study
Participants represent two subsets of mother–offspring pairs from the
national Norwegian Mother and Child Cohort Study (MoBa), a pro-
spective population-based pregnancy cohort study conducted by the
Norwegian Institute of Public Health (Magnus et al., 2006, 2016). The
years of birth for MoBa participants ranged from 1999 to 2009 and
the cohort includes more than 114 000 children, 95 000 mothers and
75 000 fathers. Two subsets of children also have cord blood DNA































































































methylation available. The two subsets are referred to here as MoBa1
and MoBa2. MoBa1 is a subset of a larger study within MoBa that
includes a cohort random sample and newborns who developed
asthma by age 3 years (Haberg et al., 2011), of which N¼ 1068 chil-
dren had cord blood DNA methylation available after quality control
exclusions (Joubert et al., 2012). MoBa2 consists of a further 685 par-
ticipants who were also a random cohort sample and newborns who
developed asthma that was still present at age seven (157 with
asthma) (Reese et al., 2019). MoBa2 participants did not overlap with
those in MoBa1 and the protocol and type of chips used for DNA
methylation analyses were the same in both subsets. Cord blood
DNA methylation data after quality control exclusions were available
in N¼ 680 MoBa2 children. MoBa1 and MoBa2 data were pooled to-
gether and N¼ 1518 (22 conceived by ART) of these had data on
ART and all the covariates included in the analysis.
Ethical approval for MoBa data was granted by Regional Committee
for Ethics in Medical Research of South/East Norway, the Norwegian
Data Inspectorate, and the Institutional Review Board of the National
Institute of Environmental Health Sciences. Written informed consent
was obtained from all MoBa participants.
Medically assisted reproduction assessment
ALSPAC participants were sent a postal questionnaire at 12 weeks
gestation that asked a two-part question: (i) ‘Did you use any treat-
ments to help conceive this pregnancy?’, a binary yes/no response,
and (ii) ‘If yes which one?’, a text answer. We used the first question
to create a binary variable for the main analysis. We used the text re-
sponse to the second question to perform a sensitivity analysis where
the medically assisted reproduction category included only mothers
who responded having used ART (IVF or gamete intrafallopian trans-
fer), IUI, or OI by hormones, whilst excluding those who reported us-
ing male infertility treatments, natural monitoring, other fertility
treatments, other treatment (not fertility), no treatment or unknown
and those with mismatches between the two questions (N¼ 7 re-
moved in ALSPAC–ARIES and N¼ 28 removed in ALSPAC-MAR).
In MoBa, ART information was obtained from the medical birth reg-
istry. The notification form completed by the midwife attending the
delivery indicated whether the pregnancy was conceived by IVF, ICSI
or other/unknown ART methods, as a single response.
DNA methylation
In the ALSPAC-ARIES and ALSPAC-MAR subsamples, DNA was
extracted from previously collected and frozen cord blood. DNA was
then bisulphite converted using Zymo EZ DNA MethylationTM kit
(Zymo, Irvine, CA, USA) and methylation was measured at 485 512
CpG sites using the Illumina Infinium HumanMethylation450K
BeadChip assay according to manufacturers’ protocols (Relton et al.,
2015). The methylation arrays were scanned with an Illumina iScan
and the initial quality was checked with GenomeStudio (version
2011.1). The methylation data pre-processed using meffil package (Min
et al., 2018). The process included quantile normalization and quality
checks such as sex chromosomes mismatches and genotype
mismatches.
In MoBa1, umbilical cord blood samples were collected and frozen
at birth at 80C. All biological material was obtained from the
Biobank of the MoBa study (Paltiel et al., 2014). Bisulphite conversion
was performed using the EZ-96 DNA Methylation kit (Zymo Research
Corporation, Irvine, CA, USA) and DNA methylation was measured
at 485 577 CpGs in cord blood using the Illumina Infinium
HumanMethylation450 BeadChip array (Joubert et al., 2012). Raw in-
tensity (.idat) files were handled in R using the minfi package to calcu-
late the methylation level at each CpG as the beta-value and the data
were exported for quality control and processing. Similar sample spe-
cific quality control was performed in MoBa1 and MoBa2, as follows:
control probes (N¼ 65) and probes on X (N¼ 11 230) and Y
(N¼ 416) chromosomes were excluded in both datasets. Remaining
CpGs missing > 10% of methylation data were also removed (N¼ 20
in MoBa1, none in MoBa2). Samples indicated by Illumina to have
failed or have an average detection P-value across all probes < 0.05
(N¼ 49 MoBa1, N¼ 35 MoBa2) and samples with gender mismatch
(N¼ 13 MoBa1, N¼ 8 MoBa2) and GWAS outliers (N¼ 6 MoBa1,
N¼ 4 MoBa2) were also removed. For MoBa1 and MoBa2, we
accounted for the two different probe designs by applying the intra-ar-
ray normalization strategy Beta Mixture Quantile dilation (BMIQ)
(Bibikova et al., 2011). After quality control exclusions, the sample
sizes of the cord blood DNA methylation data (including with missing
conception data and covariates) were 1056 for MoBa1 and 680 for
MoBa2. To account for differences between MoBa1 and MoBa2, we
also adjusted for the different design variables, such as sample pull or
selection factors (MoBa2) with a fixed effect variable.
EWAS meta-analysis
We estimated the association between medically assisted reproduction
and cord blood DNA methylation at all the CpGs that passed QC in
ALSPAC–ARIES, ALSPAC-MAR and MoBa by running linear regression
models of medically assisted reproduction (exposure) on DNA meth-
ylation (outcome) using the CpGassoc package in R (Barfield et al.,
2012). To control for batch, we included a term for bisulphite treat-
ment plate. We used an algorithm and a reference panel that is suit-
able for cord blood (Bakulski et al., 2016) to calculate cell type
composition and added estimated cell counts as covariates.
Additionally, we adjusted for infant sex at birth and potential con-
founding by maternal age at delivery, maternal BMI and maternal
smoking during the first trimester of pregnancy. In ALSPAC, maternal
pre-pregnancy weight, height and smoking were obtained through self-
report in questionnaires completed in the first trimester of pregnancy
whereas maternal age at delivery and infant sex were extracted from
obstetric records. Smoking during the first trimester was categorized
into a binary variable of ‘Did not smoke’ and ‘Smoked’. In MoBa, for
both datasets, information maternal pre-pregnancy weight height and
smoking was obtained through self-report questionnaires completed at
around 17 weeks of gestation; maternal age at delivery and infant sex
were obtained from the birth registry records. Smoking was catego-
rized in a three-level variable, ‘non-smoker’, ‘stopped early in preg-
nancy’ and ‘smoked throughout pregnancy’.
A meta-analysis of the summary statistics of the EWAS results from
each study sample (ALSPAC–ARIES, ALSPAC-MAR and MoBa) was
carried out using METAL (version 2011-03-25) (Willer et al., 2010),
using a fixed effects model with inverse variance weighting (Rice et al.,
2018). Since in the MoBa EWAS the X and Y chromosome were
omitted, the meta-analysis excluded CpGs on these chromosomes.






























































































.Replication in an independent cohort
We sought replication of results for all CpG sites with PFDR <0.05 in
the meta-analysis EWAS in an independent study sample, the ‘Clinical
review of the Health of adults conceived following Assisted
Reproductive Technologies’ (CHART) cohort. CHART is an
Australian cohort of N¼ 547 adults conceived by IVF and N¼ 549
naturally conceived controls (Lewis et al., 2017). In a subsample of
N¼ 193 ART-conceived and N¼ 86 non-ART adults who gave their
consent for epigenetic analyses, DNA methylation was measured in
DNA isolated from neonatal blood spots (Guthrie spots) that were
collected at 2–3 days after birth using the Illumina
InfiniumMethylationEPIC BeadChips array. Pre-processing was carried
out using MissMethyl and minfi R packages and normalization was per-
formed using SWAN (Maksimovic et al., 2012). Quality checks in-
volved the exclusion of samples with mean detection P-value> 0.01,
probes with detection P-value> 0.01, those associated with SNPs and
cross-reactive probes. Cell composition was estimated using the
Bakulski cord blood cell reference method (Bakulski et al., 2016).
Linear regression modelling was performed using limma R package and
included sample plate, cell proportions (six cell types), infant sex and
maternal age at delivery covariates (data were not available in this
study to adjust for potential confounding by maternal pre-pregnancy
BMI or pregnancy smoking). After quality control exclusions, there
were 146 ART cases and 58 controls with data on ART and covariates
to use in this analysis. Ethical approval for the CHART study was
granted by the Royal Children’s Hospital Human Research Ethics
Committee (RCH HREC Project 33163). All participants for this study
gave written informed consent.
Biological characterisation
CpG sites associated with medically assisted reproduction were com-
pared to those listed in the EWAS catalogue (http://www.ewascata
log.org/) in July 2019. Studies indexed by the EWAS catalogue in-
cluded at least 100 000 CpG sites in analyses and had sample sizes of
at least 100 individuals.
Gene ontology (GO) enrichment (Ashburner et al., 2000; The Gene
Ontology Consortium, 2017) for the first 100 CpG sites from the
meta-EWAS ranked by ascending P-value was conducted using the R
package missMethyl (Phipson et al., 2016). This method takes into ac-
count the differing number of probes per gene found on the array
which can otherwise bias results (Geeleher et al., 2013). Since hyper-
and hypo-methylation at CpG sites in our analysis were likely to be bi-
ologically distinct we stratified our enrichment analysis accordingly.
Enrichment analyses were conducted using the R package LOLA
(Sheffield and Bock, 2016). Input was genomic coordinates of the first
100 CpG sites from the meta-EWAS ranked by ascending P-value and
the background set was the genomic coordinates all array CpG sites
included in the meta-EWAS. The LOLA core region set was used to
test for enrichments. As above, sites were stratified into hyper- and
hypo-methylated CpG sites. For each LOLA analysis, we filtered
results retaining enriched region sets only when the support (i.e. num-
ber of regions overlapping) >¼5 and the q-value was <0.05.
To further identify enrichment of CpG sites associated with medi-
cally assisted reproduction at cell type-specific histone modifications
and DNaseI hypersensitivity sites (DHS) we used eFORGEv2.0
(Breeze et al., 2016). H3 marks and DHS were analysed from the
consolidated Roadmap Epigenomics data set. Input was the first 100
CpG sites from the EWAS when ranked by ascending P-value. The
background set of CpG sites was all CpG sites on the array analyzed
in the meta-EWAS. As above, sites were stratified into hyper- and
hypo-methylated CpG sites.
The genes mapped to the CpGs associated with medically assisted
reproduction at PFDR<0.05 and in DMRs were searched for published
associations in the GWAS catalogue (https://www.ebi.ac.uk/gwas/,
v1.0.2: 04 June 2020, date last accessed) (Buniello et al., 2019).
Methylation quantitative trait loci analysis
For each CpG associated with medically assisted reproduction in the
single-site EWAS at PFDR<0.05, we searched for methylation quantita-
tive trait loci (mQTLs) in the mQTL database (www.mqtldb.org, 10
June 2020, last date accessed) (Gaunt et al., 2016).
Results
Study sample characteristics
The characteristics of the study participants for ALSPAC–ARIES,
ALSPAC-MAR and MoBa are shown in Table I and Supplementary
Table SII. ALSPAC-MAR and MoBa included a higher proportion of
smokers during the first trimester and female offspring compared to
ALSPAC-ARIES. Mean birthweight, gestational length and maternal
pre-pregnancy BMI were similar across the three study samples. In all
three samples, mothers of infants conceived via medically assisted re-
production were older and in ALSPAC-MAR and MoBa infants con-
ceived with medically assisted reproduction were slightly more likely
to be female. In ALSPAC-MAR, and to a weaker extent ALSPAC–
ARIES, mothers of infants conceived with medically assisted reproduc-
tion were less likely to smoke and had lower BMI, which may reflect
UK guidelines that restrict some ART procedures to women with a
healthy BMI and who do not smoke at the time of treatment.
EWAS meta-analysis
Figure 1 and Table II summarize the results of the EWAS meta-analysis
adjusted for gender at birth, maternal age at delivery, maternal BMI
and maternal smoking during pregnancy. There were five CpG sites as-
sociated with medically assisted reproduction at the genome-wide level
(PFDR<0.05), four of which surpassed the threshold for Bonferroni
corrected P-values (PBonferroni<0.05). These were hyper-methylated
sites. The effect sizes were lower than 1% absolute difference in meth-
ylation between the two groups. The direction of effect was concor-
dant across studies for three of the five sites and it was concordant
for four of the five sites between the two ALSPAC subsamples. Three
of the CpG sites were located in known genes, including two sites that
were annotated to the same gene coding for arrestin domain-contain-
ing protein 1 (ARRDC4). In all three study samples methylation at
ARRDC4 was <1% higher in ART cases compared to non-ART con-
trols at unadjusted P-value< 0.05.
EWAS sensitivity analyses conducted in ALSPAC–ARIES and
ALSPAC-MAR with restriction to participants who reported specific
forms of medically assisted reproduction (IVF, intrauterine insemina-
tion, or OI by hormones) and adjusted for the same covariates as the
main analysis showed similar results to the main analyses with high



































































..correlation between the regression beta coefficients (R2¼ 0.86 for
ALSPAC–ARIES and R2¼0.95 for ALSPAC-MAR).
Further sensitivity analyses conducted by MAR procedure within the
ALSPAC subsamples (where there were enough cases to run the
analysis) showed associations with OI by hormones for all CpGs and
intrauterine insemination for cg18529845 (Supplementary Fig. S1).
Replication in CHART
In the CHART sample, there was no clear evidence of association at
any of the 5 CpG sites identified in the discovery meta-analysis
(Supplementary Table SIII).
Biological characterisation
Three of five sites associated with medically assisted reproduction at
genome-wide level in our discovery sample were previously reported
to be associated with other phenotypes according to the EWAS cata-
logue (see Supplementary Table SIV). cg18529845 and cg17855264
were associated in multiple EWAS studies of cancer, ageing and HIV
infection. cg24051276 was associated with rheumatoid arthritis, de-
mentia and palsy.
No GO terms were shown to be enriched after accounting for
multiple testing. In the hypermethylated probe set the most
highly enriched terms were biological processes linked to modulation
by host of viral process and androgen metabolism (see Supplementary
Table SV).
To identify enrichment of sites associated with medically assisted re-
production within gene and gene regulatory regions we utilized
eFORGE and LOLA. Using LOLA, enrichment was identified amongst
the set of CpG sites that were hypermethylated in cases compared to
controls (n¼ 69 of 100 sites included). Hypermethylated CpGs were
enriched for CpG islands (q¼ 0.0011) (see Supplementary Table SVI).
They were also enriched for EZH2 transcription factor binding sites
based on ENCODE data. This transcription factor is associated with
methylation of H3K27 chromatin leading to chromatin compaction
(Laugesen et al., 2019). LOLA analysis also showed that hypermethy-
lated CpG sites were strongly enriched amongst H3K4me2,
H3K4me3, H3K9me3 and H3K4me1 in breast and prostate tissues us-
ing data derived from the cistrome project.
eFORGE was used to identify cell type specific DHS in tissues
profiled by the NIH Roadmap Epigenomics consortium (see
Supplementary Table SVII). Enrichment was observed for the hyper-
methylated set. The strongest enrichment identified for DHS was
found in embryonic stem cells. The histone modifications H3K9me3
and H3K9me1 were strongly enriched in multiple tissues, including em-
bryonic stem cells, blood, ovary, stem and foetal cells. H3K9me3 is as-
sociated with decreased accessibility of chromatin and is pivotal in
lineage commitment during organogenesis and for maintaining cell line-
age in differentiated cells (Nicetto et al., 2019). H3K4 methylation was
also identified using LOLA and is typically detected in promoter
regions of active genes (Barski et al., 2007).
The ‘GWAS Catalogue’ search showed that a genetic variant in
SRD5A2, whose methylation was associated with medically assisted re-
production, had previously been found to be associated with male
baldness (Supplementary Table SVIII).
mQTL analysis
To explore the potential health consequences of medically assisted re-
production, we searched for cis-mQTLs of the top five CpGs from the
meta-analysis by looking at SNPs associated with the CpGs in the
mQTLdb database (www.mqtldb.org). We were not able to identify
any suitable mQTL from this analysis as all the SNPs associated with
the five top CpGs were located in trans (>1 kb from the CpG site).
Discussion
We conducted an EWAS meta-analysis of the association of medically
assisted reproduction with cord blood DNA methylation across two
European birth cohorts, ALSPAC and MoBa. The results showed evi-
dence of an association between medically assisted reproduction and
DNA methylation at five CpG sites. By interrogating online databases,
we also found evidence that some of the methylation differences asso-
ciated with medically assisted reproduction were associated with dis-
eases and health-related traits in adulthood. At the molecular level,
hypermethylation linked to medically assisted reproduction occurred in
regulatory sites involved in chromatin remodelling. However, we could
not confirm whether the associations of medically assisted
............................................................................................................................................................................................................................







ART (%) – – 22 (1.5)
Medically assisted reproduction (%) 28 (3.6) 155 (44.9) –
Smoked first trimester (%) 100 (12.8) 83 (24.1) 415 (27.3)
Offspring gender at birth (% female) 398 (50.6) 143 (41.4) 706 (46.5)
Maternal age (years) (mean (SD)) 29.65 (4.41) 28.84 (4.83) 29.96 (4.31)
Maternal BMI (kg/m2) (mean (SD)) 22.92 (3.80) 24.52 (6.57) 24.12 (4.32)
Birthweight (g) (mean (SD)) 3419 (481) 3364 (606) 3648 (541)
Gestational age (weeks) (mean (SD)) 39.70 (1.48) 39.33 (1.86) 39.48 (1.61)
ALSPAC, Avon Longitudinal Study of Parents and Children; ARIES, Accessible Resource for Integrated Epigenomics Studies; MAR, Medically Assisted Reproduction: MoBa, Norwegian
Mother, Father, and Child Birth Cohort.
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reproduction with differential methylation at the strongest five CpGs
were causal (or might be explained by confounding, including by the
underlying pathology resulting in infertility). Nor could we establish
whether the methylation changes were causally linked to diseases and
health-related traits using Mendelian randomization.
Several previous studies have explored differential DNA methylation
in infant blood cells related to conception by ART using either candi-
date or EWAS approaches. Most of these have had smaller sample
sizes than our study and/or have not sought replication in an indepen-
dent group. In a recent study conducted on the CHART cohort used
Figure 1. Association between cord blood DNA methyla-
tion and medically assisted reproduction estimated by the
meta-analysis. (a) Quantile–quantile plot of the observed versus
expected distribution of P-values; (b) volcano plot of the P-values
versus the beta coefficients. k¼ genomic inflation factor calculated















































































































































































































































































































































































































































































































































































































































































































































































































































as replication in our study (Novakovic et al., 2019), 18 CpG sites
were associated with ART, 9 of which were available in our study. In
our meta-analysis, at four of these nine CpGs the direction of the
effects was concordant (including at CHRNE) and with low P-values
(0.07–0.006) (Supplementary Table SIX), thus, providing some evi-
dence of consistency across studies, although none of these nine
CpGs had P-values< 0.006 (P¼ 0.05 Bonferroni-corrected to take
into account nine multiple comparisons). Differences between our
study and this one may be explained by differences in the adjustment
for confounding factors (we adjusted for batch, cell-type, maternal
pre-pregnancy BMI, pregnancy smoking, age at delivery and infant sex,
whereas the published study adjusted for batch, cell-type and infant
sex), the different sample used (blood in our study and Guthrie spots
in the published study) and/or differences in the cases definition
(broad range of treatments and self-reported in our study, whereas re-
stricted to ART and from hospital records in the published study). The
results in the published study are more generally related to ART
(which involves OI as part of the procedure and in vitro manipulation
processes), whereas the associations reported in our study seems to
be specific for procedures that did not involve in vitro gamete or em-
bryo manipulation (OI and intrauterine insemination). However, given
that the two studies were broadly similar in population, analysis meth-
ods and size, the lack of consistency between the two may be because
the findings in both studies are due to chance and do not reflect real
replicable associations. This would be consistent with the lack of repli-
cation of our findings in the CHART study.
Most of the CpGs identified in this study are located in the proxim-
ity of known genes. We found evidence of hypermethylation at the
transcription start site of the SRD5A2 gene, coding for steroid 5-alpha
Reductase 2, an enzyme involved in androgen metabolism and male
sexual development. Hypermethylation at this site was associated par-
ticularly with OI and intrauterine insemination, suggesting a specific ef-
fect of hormonal stimulation, gamete manipulation, and/or freezing
and thawing of eggs or sperm. Since our study is observational, we
cannot rule out that an impairment in this gene at the parental level
was present before having received the medical procedures to help
conceiving rather than their consequence and could be related to pa-
rental sub-fertility rather than the fertility procedures per se. The lack
of association in the replication sample at this and the other sites that
were differentially methylated in our discovery sample may be due to
the different sample collections (cord blood in our discovery meta-
analysis and Guthrie dry blood spots collected at 2–4 days in CHART).
They could also be due to heterogeneity in the cases definition be-
tween cohorts. In CHART, only those conceived by IVF, ICSI or, in a
minority of cases, other ART were included in the cases and this was
obtained from hospital records. However, the most likely interpreta-
tion is that these additional associations are driven by chance.
Our study has several strengths compared to other previously pub-
lished studies. By combining participants from different studies, we
have achieved a larger sample size. We also adjusted for potential con-
founding maternal characteristics (maternal pre-pregnancy BMI, preg-
nancy smoking and age at delivery), whereas most previous studies
had either smaller sample sizes or adjusted for fewer confounders.
Maternal BMI, smoking and age are associated with low fertility as well
as DNA methylation and including these factors is important as it par-
tially controls for confounding due to infertility. We also conducted ex-
tensive biological characterisation using freely available databases and
an mQTL look-up to attempt to determine potential causal links to
disease and health-related traits. Finally, we explored replication in an
independent sample.
This study has also some limitations. First, our definition of MAR is
heterogeneous. OI by hormones, is often used in combination with
IVF and intrauterine insemination. Therefore, it is challenging to sepa-
rate the effects of hormone stimulation from those of in vitro culturing.
In our discovery meta-analysis our main exposure was self-reported
assisted reproduction and, although we could explore in ALSPAC the
effects of OI and intrauterine insemination, the IVF groups had very
small sample sizes. In ALSPAC, participants were asked a very general
question about having used any treatment to help them conceive and
then had the opportunity to provide additional information in a text
response. In MoBa, the data were obtained from the birth register,
but the report was a single entry completed by a midwife that asked
whether the conception was by ART (defined as IVF, ICSI or other
ART) so we were unable to explore the specific effect of different pro-
cedures. Despite our meta-analysis approach, case numbers in each
cohort are small and this limitation should be addressed in future stud-
ies. Another limitation is that due to the observational nature of the
study it has not been possible to establish causality between medically
assisted reproduction and offspring DNA methylation. Even though we
adjusted for potential confounders the possibility of residual confound-
ing, for example by paternal sub-fertility, remains. Furthermore, due to
an insufficient number of mQTLs, our study did not provide the op-
portunity to conduct Mendelian randomization to explore causal
effects between methylation and disease risk.
Overall, we show that newborns conceived by medically assisted re-
production present with altered DNA methylation in cord blood white
cells. However, we cannot distinguish whether these methylation pro-
files are due to the actual fertility treatments, reflect the underlying
causes of subfertility, or are chance associations. If any are causal, we
do not know whether there are long-term consequences for offspring
health. As this is one of the largest studies to date, has adjusted for
confounders and tried to explore replication, it highlights the need for
larger studies and/or attempts to harmonize data across all studies
and undertake a larger collaborative effort. There is also a need for
studies with more detailed information on the type of fertility treat-
ment, and on the cause of parental sub-fertility. However, to the best
of our knowledge, studies with such detailed exposure information
and DNA methylation in large numbers are currently lacking.
Additional follow-up studies with DNA methylation at older ages
would also be useful to investigate a potential resolution of DNA
methylation variation associated with fertility treatments over time as
indicated by the CHART study (Novakovic, et al., 2019). Current
efforts in generating more mQTL databases such as the GoDMC con-
sortium (http://www.godmc.org.uk/) might provide additional mQTL
for use in Mendelian randomisation to establish causal links between
differential DNA methylation related to medically assisted reproduc-
tion and future disease risks.
Supplementary data
Supplementary data are available at Human Reproduction online.
































































































The data underlying this article cannot be shared publicly for the pri-
vacy of individuals that participated in the study. The data will be
shared on reasonable request to the individual cohorts. For ALSPAC,
data are available according to the procedures listed at http://www.
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